+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update

  • PDF Icon

    Report

  • 57 Pages
  • October 2024
  • Region: Global
  • GlobalData
  • ID: 6025424
The Medical Devices sector report, “Tissue Adhesives Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Tissue Adhesives pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Tissue adhesives consist of polymers that form a thin protective film and create a strong adherent bond to hold the edges of wounds on the skin. Tissue adhesives allows for proper healing of the wound under the film and protects the wound from microbial infections.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Adhesives under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Adhesives and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Adhesives under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Tissue Adhesives Overview
3 Products under Development
3.1 Tissue Adhesives - Pipeline Products by Stage of Development
3.2 Tissue Adhesives - Pipeline Products by Segment
3.3 Tissue Adhesives - Pipeline Products by Territory
3.4 Tissue Adhesives - Pipeline Products by Regulatory Path
3.5 Tissue Adhesives - Pipeline Products by Estimated Approval Date
3.6 Tissue Adhesives - Ongoing Clinical Trials
4 Tissue Adhesives - Pipeline Products under Development by Companies
4.1 Tissue Adhesives Companies - Pipeline Products by Stage of Development
4.2 Tissue Adhesives - Pipeline Products by Stage of Development
5 Tissue Adhesives Companies and Product Overview
5.1 Adhesys Medical GmbH Company Overview
5.1.1 Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview
5.2 Advanced Medical Solutions Group plc Company Overview
5.2.1 Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview
5.3 Aleo BME Inc Company Overview
5.3.1 Aleo BME Inc Pipeline Products & Ongoing Clinical Trials Overview
5.4 Alumend LLC Company Overview
5.4.1 Alumend LLC Pipeline Products & Ongoing Clinical Trials Overview
5.5 Artivion Inc Company Overview
5.5.1 Artivion Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 BioDevek Inc Company Overview
5.6.1 BioDevek Inc Pipeline Products & Ongoing Clinical Trials Overview
5.7 DialyFlux LLC Company Overview
5.7.1 DialyFlux LLC Pipeline Products & Ongoing Clinical Trials Overview
5.8 Emory University Company Overview
5.8.1 Emory University Pipeline Products & Ongoing Clinical Trials Overview
5.9 Hansjorg Wyss Institute for Biologically Inspired Engineering Company Overview
5.9.1 Hansjorg Wyss Institute for Biologically Inspired Engineering Pipeline Products & Ongoing Clinical Trials Overview
5.10 Harvard University Company Overview
5.10.1 Harvard University Pipeline Products & Ongoing Clinical Trials Overview
5.11 Kollodis BioSciences Inc Company Overview
5.11.1 Kollodis BioSciences Inc Pipeline Products & Ongoing Clinical Trials Overview
5.12 Massachusetts Institute of Technology Company Overview
5.12.1 Massachusetts Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview
5.13 Medisse BV (Inactive) Company Overview
5.13.1 Medisse BV (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 N8 Medical LLC Company Overview
5.14.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.15 Nanyang Technological University Company Overview
5.15.1 Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
5.16 Northwestern University Company Overview
5.16.1 Northwestern University Pipeline Products & Ongoing Clinical Trials Overview
5.17 OptMed Inc Company Overview
5.17.1 OptMed Inc Pipeline Products & Ongoing Clinical Trials Overview
5.18 Purdue University Company Overview
5.18.1 Purdue University Pipeline Products & Ongoing Clinical Trials Overview
5.19 Tissium SA Company Overview
5.19.1 Tissium SA Pipeline Products & Ongoing Clinical Trials Overview
5.20 University of Galway Company Overview
5.20.1 University of Galway Pipeline Products & Ongoing Clinical Trials Overview
5.21 University of Kansas Company Overview
5.21.1 University of Kansas Pipeline Products & Ongoing Clinical Trials Overview
6 Tissue Adhesives- Recent Developments
6.1 Aug 30, 2024: Okapi Medical Receives 510(k) Clearance For Cutiva Topical Skin Adhesive
6.2 Jul 29, 2024: Connexicon Medical Receives FDA 510(k) Clearance for CM005 Standard (CM005)
6.3 Jul 29, 2024: Connexicon Medical Receives FDA 510(k) Clearance for CM00622 LINC Skin Closure System (CM00622 LINC)
6.4 Jul 29, 2024: Connexicon Receives FDA 510(k) Clearance for CM004 Mini (CM004)
6.5 Mar 22, 2024: Meril Endo Surgery Received FDA 510(K) Clearance For Meriglu Topical Skin Adhesive
6.6 Oct 18, 2023: NeoDyne Launches New UK Headquarters to Mark Growth and Expansion in the UK
7 Appendix
7.1 Methodology
7.2 About the Analyst
7.3 Contact the Publisher
7.4 Disclaimer
List of Tables
  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Segment
  • Tissue Adhesives - Pipeline Products by Territory
  • Tissue Adhesives - Pipeline Products by Regulatory Path
  • Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • Tissue Adhesives - Ongoing Clinical Trials
  • Tissue Adhesives Companies - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Glossary
List of Figures
  • Tissue Adhesives - Pipeline Products by Stage of Development
  • Tissue Adhesives - Pipeline Products by Segment
  • Tissue Adhesives - Pipeline Products by Territory
  • Tissue Adhesives - Pipeline Products by Regulatory Path
  • Tissue Adhesives - Pipeline Products by Estimated Approval Date
  • Tissue Adhesives - Ongoing Clinical Trials

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adhesys Medical GmbH
  • Advanced Medical Solutions Group plc
  • Aleo BME Inc
  • Alumend LLC
  • Artivion Inc
  • BioDevek Inc
  • DialyFlux LLC
  • Emory University
  • Hansjorg Wyss Institute for Biologically Inspired Engineering
  • Harvard University
  • Kollodis BioSciences Inc
  • Massachusetts Institute of Technology
  • Medisse BV (Inactive)
  • N8 Medical LLC
  • Nanyang Technological University
  • Northwestern University
  • OptMed Inc
  • Purdue University
  • Tissium SA
  • University of Galway
  • University of Kansas